Net revenue rose 12% to $12.5 billion, operating income increased 19%, and EPS climbed 18% to $0.91, with global unit case volume up 3%.
The company gained value share in nonalcoholic ready-to-drink beverages, driven by successful local marketing and product innovation across key markets such as China, Brazil, and the US.
Coca-Cola raised its annual comparable EPS growth forecast to 8-9% and expects 4-5% organic revenue growth in 2026, reflecting resilience amid global challenges and recent leadership transition to CEO Henrique Braun.
Can new 'healthy' drinks truly replace the profits from its declining core soda business?
Is Coca-Cola's strong revenue growth from genuine innovation or just temporary price hikes?
Will Coca-Cola's expansion into alcohol create new public health challenges globally?
As Coca-Cola embraces alcohol, can it maintain its iconic family-friendly brand identity?
How will shareholder pressure on sustainability impact the company's long-term strategy?
How does the company justify its massive marketing spend on community while resisting ESG reforms?